Literature DB >> 7923712

[Effect of acupuncture on T-lymphocyte and its subsets from the peripheral blood of patients with malignant neoplasm].

J Yuan1, R Zhou.   

Abstract

Effect of acupuncture on the T-lymphocyte and its subsets from the peripheral blood of patients with malignant neoplasm has been researched in this study. 51 patients were divided into two groups: one in acupuncture treatment and the other without any treatment. 48 healthy adults were also studied as normal control group. The results showed that the percentages of OKT3+, OKT4+, OKT8+ cells in the peripheral blood of the 51 patients were lower than those of the normal adults respectively. After the acupuncture treatment, the percentages of OKT3+, OKT4+, OKT8+ cells were obviously higher than those before acupuncture; the control group of patients showed no significant variation. This result revealed that acupuncture seemed to have more affect on OKT4+ cells than on OKT8+ cells. From our study we believe that acupuncture can be used as one of the many treatments for patients with cancer.

Entities:  

Mesh:

Year:  1993        PMID: 7923712

Source DB:  PubMed          Journal:  Zhen Ci Yan Jiu        ISSN: 1000-0607


  4 in total

Review 1.  Acupuncture for Neoplasms: An Update from the PubMed Database.

Authors:  Guangjun Wang; Gerhard Litscher
Journal:  Med Acupunct       Date:  2015-06-01

Review 2.  Chinese herbal medicine for myelosuppression induced by chemotherapy or radiotherapy: a systematic review of randomized controlled trials.

Authors:  Youji Jia; Huihui Du; Min Yao; Xuejun Cui; Qi Shi; Yongjun Wang; Yanping Yang
Journal:  Evid Based Complement Alternat Med       Date:  2015-02-23       Impact factor: 2.629

Review 3.  Acupuncture as anticancer treatment?

Authors:  Paulina Frączek; Aneta Kilian-Kita; Mirosława Püsküllüoglu; Krzysztof Krzemieniecki
Journal:  Contemp Oncol (Pozn)       Date:  2017-01-12

4.  Electro-acupuncture in relieving labor pain.

Authors:  Fan Qu; Jue Zhou
Journal:  Evid Based Complement Alternat Med       Date:  2006-08-17       Impact factor: 2.629

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.